Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
30.5M
-
Shares change
-
+1.2M
-
Total reported value, excl. options
-
$1.22B
-
Value change
-
+$50.1M
-
Number of buys
-
36
-
Number of sells
-
-27
-
Price
-
$40.06
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2017
77 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q4 2017.
Ascendis Pharma A/S - ADR (ASND) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.5M shares
of 55.6M outstanding shares and own 54.91% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (5.58M shares), FMR LLC (3.63M shares), ORBIMED ADVISORS LLC (3.37M shares), BAKER BROS. ADVISORS LP (2.62M shares), EcoR1 Capital, LLC (2.11M shares), Vivo Capital, LLC (1.77M shares), venBio Select Advisor LLC (1.68M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.33M shares), VHCP Management II, LLC (1.11M shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (789K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.